Medical library

Step 3 · 7–9%

Pregnancy, Female Reproductive & Breast

Prenatal care to postpartum, then contraception, menses, menopause, infections and breast.

See it in the Brain

Prenatal care & screening

In the Brain

Date the pregnancy well, run each screen in its window, and stop harmful drugs and exposures early.

Rules to know

  • First prenatal visit labs → CBC, blood type and antibody screen, rubella IgG, HBsAg, HIV, syphilis, hepatitis C, urine culture; chlamydia and gonorrhea if under 25 or at risk
  • Dating the pregnancy → first-trimester crown-rump length wins; change the due date if period dates differ by >5 days before 9 weeks or >7 days through 13 weeks
  • Routine prenatal visit schedule → every 4 weeks until 28 weeks, every 2 weeks until 36 weeks, then weekly until birth
  • Aneuploidy screening → offer to every patient at any age; cell-free DNA from 10 weeks is the most sensitive screen but is not diagnostic
  • Positive cell-free DNA or serum screen → genetic counseling and diagnostic testing (CVS at 10–13 weeks or amniocentesis from 15 weeks) before any irreversible decision
  • Cell-free DNA returns no result (low fetal fraction) → counsel about higher aneuploidy risk; offer detailed ultrasound and diagnostic testing
  • Open neural tube defect screening → maternal serum AFP at 15–22 weeks or a detailed anatomy scan; cell-free DNA does not detect these
  • High maternal serum AFP → confirm dates by ultrasound first, then a targeted scan for neural tube or abdominal wall defect, twins or fetal death
  • Quad screen with low AFP and estriol, high hCG and inhibin → trisomy 21 pattern; all low except inhibin points to trisomy 18
  • Carrier screening → offer cystic fibrosis, spinal muscular atrophy and hemoglobinopathy screening (CBC with MCV, electrophoresis if indicated) to everyone; a carrier's partner is tested next
  • Gestational diabetes screening at 24–28 weeks → 50-g 1-hour challenge then 100-g 3-hour test if high, or a single 75-g 2-hour test
  • Overweight with prior gestational diabetes, PCOS or strong family history → screen for diabetes at the first visit; repeat at 24–28 weeks if normal
  • Group B strep screening → rectovaginal culture at 36–37 weeks; skip it when GBS bacteriuria this pregnancy or a prior infected infant already mandates labor prophylaxis
  • Rh-negative, antibody screen negative → anti-D immune globulin at 28 weeks, after bleeding, trauma or procedures, and within 72 h of birth if the newborn is Rh-positive
  • Rh-negative with anti-D antibodies already present → immune globulin no longer helps; follow titers, then serial MCA Doppler for fetal anemia once titers are critical
  • Syphilis screening in pregnancy → first visit, again near 28 weeks and at delivery, given rising congenital syphilis
  • Bacteriuria on first-visit culture without symptoms → treat per sensitivities (cephalexin, nitrofurantoin, fosfomycin) and repeat the culture; untreated it can progress to pyelonephritis
  • Each pregnancy → Tdap at 27–36 weeks, inactivated influenza in season, RSV vaccine at 32–36 weeks September–January unless the infant will receive nirsevimab
  • Nonstress test after 32 weeks → reactive if two accelerations of 15 bpm lasting 15 seconds within 20 minutes; nonreactive → biophysical profile or contraction stress test
  • Biophysical profile score → 8–10 reassuring; 6 equivocal (deliver at term, otherwise repeat within 24 h); 4 or less usually means delivery
  • Decreased fetal movement in the third trimester → same-day nonstress test and amniotic fluid check, not reassurance by phone
  • Fundal height off by >3 cm at 24–38 weeks → ultrasound for fetal growth and amniotic fluid
  • Planning pregnancy on ACE inhibitor, ARB, warfarin, valproate, methotrexate, mycophenolate or isotretinoin → switch or stop before conception
  • Antibiotics in pregnancy → penicillins, cephalosporins, azithromycin and clindamycin are safe; avoid tetracyclines and fluoroquinolones, and TMP-SMX in the first trimester and near term
  • Pain or fever in pregnancy → acetaminophen at the lowest effective dose; avoid NSAIDs from 20 weeks (oligohydramnios, early ductus closure)
  • Needed CT or x-ray during pregnancy → proceed; fetal doses under 50 mGy carry no measurable anomaly risk; iodinated contrast is acceptable, gadolinium is avoided
  • Opioid use disorder in pregnancy → buprenorphine or methadone rather than withdrawal; plan ahead for neonatal opioid withdrawal care
  • Alcohol, tobacco or cannabis use in pregnancy → advise stopping all; no amount of alcohol is known safe; counseling first for smoking, nicotine replacement if that fails

Traps that cost points

  • Offering amniocentesis or CVS only to patients 35 and older→ Every patient is offered screening and diagnostic testing; age changes the risk, not the eligibility.
  • Treating a positive cell-free DNA result as a diagnosis→ False positives occur, especially in low-risk patients; confirm with CVS or amniocentesis before any decision.
  • Giving anti-D globulin to an Rh-negative patient who is already sensitized→ Once antibodies exist the globulin cannot help; follow titers and screen the fetus for anemia with MCA Doppler.
  • Working up a high AFP before checking the dates→ Wrong gestational age is the most common explanation; date by ultrasound first, then do a targeted anatomy scan.
  • Withholding a needed CT from a pregnant patient with trauma or suspected PE→ Diagnostic doses sit far below harmful thresholds; a missed diagnosis is the greater danger to mother and fetus.
  • Advising a pregnant patient with opioid use disorder to taper off→ Withdrawal raises relapse, overdose and fetal stress; start or continue buprenorphine or methadone.
  • Stopping a needed SSRI or antiseizure drug as soon as pregnancy is confirmed→ Untreated illness carries its own risk; continue effective drugs and switch only clear teratogens such as valproate.
  • Ordering routine TSH and vitamin D panels at the first visit for everyone→ Test thyroid only with symptoms or risk factors; the core panel is blood type, antibodies, infections and urine culture.

Medical complications of pregnancy

In the Brain

Hypertensive disorders and diabetes dominate: know the thresholds, the drug of choice and the week to deliver, plus the key infections.

Rules to know

  • Aspirin to prevent preeclampsia → 81 mg daily started at 12–28 weeks, ideally before 16, and continued until delivery
  • Aspirin candidates in pregnancy → prior preeclampsia, chronic hypertension, pregestational diabetes, kidney disease, lupus or antiphospholipid syndrome, twins, or two or more moderate risks
  • New hypertension after 20 weeks without proteinuria or severe features → gestational hypertension (≥140/90 twice, 4 h apart); weekly labs, fetal testing, deliver at 37 weeks
  • Hypertension after 20 weeks plus proteinuria or end-organ signs → preeclampsia; protein/creatinine ≥0.3, or low platelets, rising creatinine, high transaminases, pulmonary edema, new headache
  • Severe features of preeclampsia → BP ≥160/110, platelets <100,000, transaminases twice normal, creatinine >1.1, pulmonary edema, persistent headache or visual changes
  • Preeclampsia without severe features → twice-weekly BP, weekly labs and fetal testing; deliver at 37 weeks
  • Preeclampsia with severe features at 34 weeks or later → magnesium, control BP, deliver after stabilizing; vaginal birth is acceptable
  • Severe preeclampsia before 34 weeks, mother and fetus stable → tertiary center, betamethasone, magnesium, daily labs; deliver if anything worsens
  • BP ≥160/110 for 15 minutes in pregnancy or postpartum → IV labetalol, IV hydralazine or oral immediate-release nifedipine within 30–60 minutes
  • Magnesium sulfate for seizure prophylaxis → 4–6 g IV load, then 1–2 g/h through delivery and 24 h after; reduce the dose with renal impairment
  • Lost reflexes, slow breathing or heart block on magnesium → stop the infusion, give IV calcium gluconate, support ventilation
  • Seizure after 20 weeks or postpartum without another cause → eclampsia; protect the airway, left lateral position, magnesium; deliver once the mother is stable
  • Hemolysis, rising transaminases, falling platelets, RUQ pain → HELLP; magnesium and delivery, with a steroid course first only if under 34 weeks and stable
  • Chronic hypertension in pregnancy → treat to below 140/90 with labetalol or long-acting nifedipine; baseline creatinine, LFTs, platelets and urine protein
  • Gestational diabetes → nutrition therapy and activity with 4-times-daily glucose checks; targets fasting <95, 1 h after meals <140 or 2 h <120
  • Gestational diabetes above target despite diet → insulin first-line; metformin is an alternative but crosses the placenta; glyburide is less preferred
  • After gestational diabetes → 75-g 2-hour glucose tolerance test at 4–12 weeks postpartum, then diabetes screening every 1–3 years for life
  • Pregestational diabetes planning pregnancy → A1c below 6.5% if safely reached, retinal exam and kidney tests; in pregnancy, aspirin from 12 weeks and fetal echocardiography
  • Pregnant patient on levothyroxine → raise the dose about 25–30% (two extra doses weekly) right away; TSH every 4 weeks through midpregnancy
  • DVT or PE in pregnancy → therapeutic LMWH through pregnancy and at least 6 weeks postpartum (3 months minimum); avoid warfarin and DOACs before delivery
  • Epilepsy in pregnancy → continue the drug that works and avoid valproate; lamotrigine levels fall, so monitor and adjust, then reduce after delivery
  • Antiphospholipid syndrome in pregnancy → low-dose aspirin plus prophylactic LMWH; therapeutic LMWH if there was a prior thrombosis
  • Itching of palms and soles in the third trimester, high bile acids → intrahepatic cholestasis; ursodiol, deliver at 36–39 weeks (36 if bile acids ≥100)
  • Third-trimester vomiting, jaundice, hypoglycemia and coagulopathy → acute fatty liver of pregnancy; correct glucose and clotting, deliver promptly
  • Pyelonephritis in pregnancy → admit, IV ceftriaxone after culture, oral once afebrile, then suppressive antibiotics for the rest of pregnancy
  • HIV in pregnancy → ART for all; viral load >1,000 near term → cesarean at 38 weeks plus IV zidovudine; suppressed → vaginal birth
  • HBsAg-positive mother → check HBV DNA; tenofovir from 28–32 weeks if >200,000 IU/mL; newborn gets HBIG plus vaccine within 12 hours
  • History of genital herpes → suppressive acyclovir or valacyclovir from 36 weeks; active lesions or prodrome in labor → cesarean
  • Nonimmune pregnant patient exposed to chickenpox → varicella-zoster immune globulin within 10 days; acyclovir if infection develops, IV for pneumonia
  • Parvovirus infection in pregnancy → serial MCA Doppler for 8–12 weeks; fetal anemia or hydrops → intrauterine transfusion

Traps that cost points

  • Waiting for proteinuria before calling preeclampsia in a hypertensive patient with low platelets→ Severe features alone define preeclampsia; proteinuria is not required once end-organ signs appear.
  • Relying on magnesium to bring down a severe-range blood pressure→ Magnesium prevents seizures only; severe-range BP needs labetalol, hydralazine or nifedipine within the hour.
  • Giving a benzodiazepine or phenytoin first for an eclamptic seizure→ Magnesium sulfate stops and prevents recurrence best; other drugs are backups when magnesium fails or is unavailable.
  • Rushing to emergency cesarean for fetal bradycardia during an eclamptic seizure→ The fetal heart usually recovers after the seizure; stabilize the mother first, then plan delivery.
  • Choosing glyburide as the first drug for gestational diabetes→ Insulin is preferred; metformin is the alternative. Glyburide causes more neonatal hypoglycemia and macrosomia.
  • Continuing an ACE inhibitor after a positive pregnancy test→ ACE inhibitors and ARBs injure fetal kidneys and cause oligohydramnios; switch to labetalol or nifedipine.
  • Starting warfarin for a DVT found at 20 weeks→ Warfarin crosses the placenta; LMWH is the antepartum drug. Warfarin is fine postpartum, including with breastfeeding.
  • Skipping postpartum glucose testing after gestational diabetes→ Later type 2 diabetes is common; do a 2-hour OGTT at 4–12 weeks, then screen every 1–3 years.

Early pregnancy: bleeding, ectopic, loss & vomiting

In the Brain

Every first-trimester bleed is an ectopic until proven otherwise: pair hCG with transvaginal ultrasound and let stability decide the path.

Rules to know

  • Positive pregnancy test with bleeding or pain → vital signs, transvaginal ultrasound, quantitative hCG, CBC, blood type and Rh
  • Pregnant, hypotensive, peritoneal signs or free fluid on FAST → ruptured ectopic; fluids, blood and surgery without waiting for hCG
  • No intrauterine pregnancy on transvaginal scan with hCG above about 3,500 → ectopic or failed pregnancy likely; if stable and pregnancy wanted, repeat hCG before treating
  • Pregnancy of unknown location, stable → repeat hCG in 48 hours with ultrasound; a viable pregnancy usually rises at least 35%
  • Methotrexate for ectopic → stable, unruptured, reliable follow-up, no intrauterine pregnancy, normal blood counts, liver and kidney tests, not breastfeeding
  • Ectopic with high hCG, cardiac activity or large mass → methotrexate likely to fail (hCG >5,000, embryonic heartbeat, mass >3.5 cm); laparoscopic surgery preferred
  • After single-dose methotrexate → hCG on days 4 and 7; a fall of 15% or more → weekly until undetectable; less → second dose or surgery
  • On methotrexate for ectopic → no folate supplements, NSAIDs, alcohol or strong sun; new severe pain → evaluate for rupture
  • Surgery for ectopic with a healthy opposite tube → salpingectomy; salpingostomy keeps the tube but needs weekly hCG for persistent trophoblast
  • Rh-negative patient with ectopic or molar pregnancy → give anti-D immune globulin
  • Rh-negative with miscarriage or abortion before 12 weeks → current guidance allows omitting anti-D; give it from 12 weeks on
  • Nonviable pregnancy criteria → crown-rump length ≥7 mm without a heartbeat, or mean sac diameter ≥25 mm without an embryo; below these, rescan in 7–14 days
  • Bleeding, closed os, live intrauterine pregnancy → threatened miscarriage; reassure, bed rest does not help, most pregnancies continue
  • Open os, tissue in the canal, heavy bleeding → inevitable or incomplete miscarriage; uterine aspiration if unstable or bleeding heavily
  • Early pregnancy loss, stable → expectant care, medication or uterine aspiration are all reasonable; the patient chooses
  • Medical management of early loss → mifepristone 200 mg, then misoprostol 800 mcg vaginally a day later; better than misoprostol alone
  • Fever, uterine tenderness and foul discharge after loss or abortion → septic abortion; blood cultures, broad IV antibiotics and prompt uterine evacuation
  • Single first-trimester loss → usually fetal aneuploidy; reassure that work, exercise and sex did not cause it; no workup needed
  • Two or more pregnancy losses → antiphospholipid antibodies, parental karyotypes, uterine cavity imaging, TSH and A1c
  • Vomiting with weight loss >5%, ketonuria, electrolyte changes → hyperemesis gravidarum; ultrasound for twins or molar pregnancy, check electrolytes, TSH and LFTs
  • Nausea and vomiting of pregnancy → pyridoxine with or without doxylamine first; add an antihistamine, metoclopramide or ondansetron if needed
  • Hyperemesis needing IV fluids → thiamine before dextrose; admit if fluids cannot be kept down or ketosis persists after outpatient therapy
  • Hyperemesis with low TSH, high free T4, no Graves signs → gestational transient thyrotoxicosis; no antithyroid drugs, settles by midpregnancy
  • Uterus large for dates, very high hCG, snowstorm ultrasound → molar pregnancy; suction curettage after baseline hCG and chest x-ray
  • Preeclampsia before 20 weeks or hyperthyroidism with very high hCG → suspect a molar pregnancy
  • After molar evacuation → weekly hCG until undetectable, then monthly checks for several months, with reliable contraception throughout
  • hCG plateaus or rises after molar evacuation → gestational trophoblastic neoplasia; chest imaging and staging, methotrexate for low-risk disease
  • Abnormal bleeding or lung nodules months after any pregnancy → check hCG for choriocarcinoma

Traps that cost points

  • Sending home a patient with pain because hCG is below the discriminatory level→ Ectopics occur at any hCG; with an empty uterus follow hCG every 48 hours and give strict return precautions.
  • Giving methotrexate after one hCG value in a stable patient who wants the pregnancy→ Confirm nonviability with a repeat hCG or scan first; methotrexate would end an early viable pregnancy.
  • Choosing methotrexate for a breastfeeding patient or one with liver disease→ These are contraindications; laparoscopic surgery is the safer option.
  • Prescribing bed rest for threatened miscarriage→ It does not prevent loss and adds clot risk; normal activity is fine.
  • Running dextrose before thiamine in a patient vomiting for weeks→ Glucose without thiamine can precipitate Wernicke encephalopathy; give thiamine first.
  • Starting methimazole for low TSH in hyperemesis→ hCG stimulates the thyroid temporarily; it resolves by about 20 weeks. Treat only true Graves disease.
  • Stopping hCG follow-up once a patient feels well after molar evacuation→ Persistent trophoblastic disease is silent; follow hCG to undetectable and beyond, and prevent a new pregnancy meanwhile.

Breast & gynecologic cancers and screening

In the Brain

Pick the first image by age, biopsy anything suspicious whatever the imaging says, and follow current screening intervals.

Rules to know

  • Average-risk woman 40–74 → screening mammography every 2 years; beyond 75 decide by health and life expectancy
  • Palpable breast mass under age 30 → targeted ultrasound first; mammogram only if ultrasound is suspicious
  • Palpable breast mass at 30 or older → diagnostic mammogram plus targeted ultrasound
  • Suspicious breast imaging (BI-RADS 4 or 5) → image-guided core needle biopsy
  • Clinically worrisome lump with normal mammogram and ultrasound → biopsy anyway; normal imaging never clears a suspicious mass
  • Simple breast cyst on ultrasound → aspirate only if painful; bloody fluid or a mass remaining after aspiration → biopsy
  • Smooth, mobile, rubbery mass in a young woman → fibroadenoma; ultrasound with core biopsy or follow-up; large, fast-growing → excise for phyllodes tumor
  • Spontaneous one-sided bloody discharge from a single duct → mammogram and ultrasound; usually intraductal papilloma, excise to exclude cancer
  • Red, swollen, peau d'orange breast that does not settle on antibiotics → inflammatory breast cancer; imaging plus core and skin punch biopsy
  • Scaly, eroded nipple that will not heal → Paget disease of the breast; mammogram and full-thickness nipple biopsy
  • Family history of breast or ovarian-type cancers, or BRCA-linked ancestry → familial risk tool; positive → genetic counseling, then testing
  • BRCA1 or BRCA2 carrier → yearly breast MRI from 25, add mammography at 30; salpingo-oophorectomy at 35–40 (BRCA1) or 40–45 (BRCA2)
  • Lifetime breast cancer risk ≥20% or chest radiation in youth → yearly MRI plus mammography, usually starting by 30
  • Increased breast cancer risk, age 35+, low clot risk → offer tamoxifen, raloxifene or an aromatase inhibitor; tamoxifen raises endometrial cancer and VTE
  • Hormone receptor–positive breast cancer → 5–10 years of endocrine therapy: tamoxifen before menopause, aromatase inhibitor after (with DXA monitoring)
  • Breast cancer survivor without symptoms → yearly history, exam and mammogram; no routine tumor markers, bone scans or CT
  • Cervical screening ages 21–29 → cytology every 3 years; nothing before 21
  • Cervical screening ages 30–65 → primary HPV test every 5 years preferred; cotesting every 5 or cytology every 3 years acceptable
  • Over 65 with adequate negative screening and no CIN2+ in 25 years → stop; total hysterectomy for benign disease → stop
  • HIV or organ transplant → cervical screening from diagnosis, cytology yearly for 3 years then every 3 years, continuing past 65
  • ASC-US at 25 or older → reflex HPV; HPV-negative → repeat testing in 3 years; HPV-positive → colposcopy
  • HPV 16 or 18 positive even with normal cytology → colposcopy; other high-risk types with normal cytology → repeat in 1 year
  • LSIL → colposcopy; HSIL → colposcopy, or immediate LEEP if 25 or older and not pregnant
  • ASC-US or LSIL at ages 21–24 → repeat cytology in 1 year instead of colposcopy
  • Abnormal cervical cytology in pregnancy → colposcopy is safe; no endocervical curettage, defer treatment of precancer until after delivery
  • Atypical glandular cells → colposcopy with endocervical sampling, plus endometrial biopsy if 35 or older or at risk
  • Visible cervical lesion or postcoital bleeding with a mass → biopsy the lesion; cytology is not a diagnostic test
  • Postmenopausal bleeding → transvaginal ultrasound (endometrium ≤4 mm reassuring) or endometrial biopsy; persistent bleeding → biopsy regardless of thickness
  • Endometrial hyperplasia with atypia → hysterectomy; without atypia → progestin, preferably levonorgestrel IUD, and repeat sampling
  • Bloating, early satiety, pelvic mass after menopause → transvaginal ultrasound and CA-125; refer to a gynecologic oncologist for surgery

Traps that cost points

  • Reassuring a woman with a firm lump because her mammogram was normal→ Mammography misses some palpable cancers, especially in dense breasts; image with ultrasound and biopsy a suspicious lump.
  • Ordering mammography first for a 24-year-old with a breast lump→ Young dense tissue images poorly on mammography; ultrasound is the first test.
  • Repeating antibiotics for persistent breast redness in a nonlactating woman→ If it does not clear quickly, image and biopsy for inflammatory carcinoma.
  • Doing yearly cervical cytology in a healthy 35-year-old with normal results→ Over-screening detects transient HPV changes and leads to needless procedures; primary HPV every 5 years.
  • Sending a 22-year-old with LSIL straight to colposcopy→ Low-grade changes usually regress in young women; repeat cytology in a year.
  • Stopping cervical screening at 65 in a woman with HIV or no documented negatives→ Stop only after an adequate negative history; immunocompromised patients continue lifelong.
  • Screening an average-risk woman for ovarian cancer with CA-125 and ultrasound→ It does not lower deaths and false positives lead to surgery; screening is for high-risk genetic pathways only.
  • Ignoring recurrent postmenopausal bleeding because the stripe measured 3 mm→ A thin stripe lowers risk, but persistent bleeding still needs tissue sampling.

Labor & delivery

In the Brain

Know normal labor's timelines, answer fetal heart tracings in order, and recognize the delivery-room emergencies.

Rules to know

  • Long latent phase below 6 cm → not a cesarean indication; rest, oxytocin or amniotomy, since active labor starts at 6 cm
  • No cervical change at ≥6 cm with ruptured membranes → active-phase arrest after 4 h of adequate or 6 h of oxytocin-augmented contractions; cesarean
  • No descent despite prolonged pushing → second-stage arrest after ≥3 h (nullipara) or ≥2 h (multipara), longer with epidural; operative vaginal birth or cesarean
  • Third stage of labor → placenta usually within 30 minutes; oxytocin right after the birth lowers hemorrhage risk
  • Category I fetal heart tracing → baseline 110–160, moderate variability, no late or variable decelerations; continue routine monitoring
  • Early decelerations mirroring contractions → fetal head compression; benign, no action needed
  • Late decelerations → uteroplacental insufficiency; left lateral position, stop oxytocin, IV fluid, correct hypotension; persistent with minimal variability → deliver
  • Recurrent variable decelerations → cord compression; reposition, check for cord prolapse, consider amnioinfusion
  • Category III tracing (absent variability with recurrent decelerations or bradycardia, or sinusoidal) → in-utero resuscitation and prepare for immediate delivery
  • More than 5 contractions per 10 minutes with tracing changes → tachysystole; stop oxytocin, give terbutaline if the tracing does not recover
  • Prolonged deceleration right after epidural placement → maternal hypotension; IV fluid, phenylephrine or ephedrine, lateral position
  • Fever in labor with fetal tachycardia or uterine tenderness → intraamniotic infection; ampicillin plus gentamicin, acetaminophen, deliver; cesarean only for usual reasons
  • Cord felt or seen after membranes rupture → hold the presenting part up off the cord, knee-chest position, emergency cesarean
  • Head delivers then retracts against the perineum → shoulder dystocia; call for help, McRoberts with suprapubic pressure, then deliver the posterior arm; no fundal pressure
  • Intrapartum GBS prophylaxis → IV penicillin G; low-risk penicillin allergy → cefazolin; high-risk allergy → clindamycin if susceptible, otherwise vancomycin
  • Unknown GBS status in labor → prophylaxis if preterm, membranes ruptured ≥18 h, temperature ≥38 °C, or positive rapid intrapartum test
  • Membranes ruptured at term without labor → induce with oxytocin rather than wait; GBS prophylaxis as indicated
  • Breech at 37 weeks → offer external cephalic version; if declined or unsuccessful, planned cesarean in most settings
  • Bishop score ≤6 before induction → cervical ripening with misoprostol, Foley balloon or dinoprostone; no misoprostol with a uterine scar
  • Low-risk pregnancy at 39 weeks → elective induction is reasonable and does not raise cesarean rates; at 41 weeks offer induction and start fetal testing
  • One or two prior low transverse cesareans → trial of labor is reasonable; prior classical incision or rupture → repeat cesarean at 36–37 weeks
  • Fetal bradycardia and lost station in labor after cesarean → uterine rupture; emergency laparotomy
  • Estimated fetal weight ≥5,000 g, or ≥4,500 g with diabetes → offer planned cesarean
  • Twin delivery timing → dichorionic at 38 weeks, monochorionic-diamniotic at 34–37 weeks; first twin not head-down → cesarean
  • Patient on LMWH approaching delivery → no neuraxial block within 12 h of a prophylactic or 24 h of a therapeutic dose
  • Cesarean prophylaxis → cefazolin within 60 minutes before incision; add azithromycin if laboring or membranes ruptured

Traps that cost points

  • Calling arrest of labor at 4–5 cm after two hours without change→ That is still latent labor; arrest requires ≥6 cm, ruptured membranes and the 4- or 6-hour criteria.
  • Applying fundal pressure for shoulder dystocia→ It wedges the shoulder harder behind the pubis; use McRoberts and suprapubic pressure, then posterior arm or rotation.
  • Keeping oxytocin running through recurrent late decelerations→ Stop oxytocin first, reposition, give fluid, fix hypotension; deliver if the tracing does not improve.
  • Ripening the cervix with misoprostol after a prior cesarean→ Prostaglandins raise uterine rupture risk with a scar; use a Foley balloon or oxytocin.
  • Going to cesarean because of intraamniotic infection alone→ Infection calls for antibiotics and delivery, not surgery; deliver vaginally unless usual obstetric indications arise.
  • Pushing a prolapsed cord back into the uterus→ Elevate the presenting part off the cord and keep it there until the cesarean is underway.
  • Choosing clindamycin for GBS in a patient whose penicillin allergy was a mild rash→ Low-risk allergy → cefazolin, which reliably covers GBS; clindamycin only for high-risk allergy with proven susceptibility.
  • Scheduling a repeat cesarean for every patient with a prior low transverse incision→ Trial of labor is a safe, reasonable choice for most; counsel and let the patient decide.

Preterm birth, ruptured membranes & late-pregnancy bleeding

In the Brain

Buy time for steroids when it helps, keep fingers out until previa is excluded, and deliver when mother or fetus cannot wait.

Rules to know

  • Preterm contractions with cervical change at 24–34 weeks → betamethasone, nifedipine tocolysis for 48 h, GBS prophylaxis if status unknown
  • Antenatal steroid timing → betamethasone when birth is likely within 7 days at 24–34 weeks; one rescue course if the first was ≥14 days earlier
  • Birth likely at 34–36 weeks, no prior steroids → late preterm betamethasone may be given; watch newborn glucose
  • Delivery likely before 32 weeks → magnesium sulfate for fetal neuroprotection against cerebral palsy
  • Indomethacin for tocolysis → only before 32 weeks and no longer than 48 h (ductal constriction, oligohydramnios)
  • Preterm contractions with negative fetal fibronectin or cervix >30 mm → birth within 2 weeks unlikely; avoid tocolysis and long admission
  • Prior spontaneous preterm birth → cervical length every 1–2 weeks from 16 to 24 weeks; cerclage if it falls below 25 mm
  • Short cervix ≤20 mm in midpregnancy, no prior preterm birth → vaginal progesterone
  • Painless second-trimester dilation or prior painless midtrimester losses → cervical insufficiency; cerclage, history-indicated placement at 12–14 weeks
  • Fluid leaking before labor → sterile speculum for pooling, nitrazine and ferning, no digital exam; ultrasound fluid volume if unclear
  • PPROM before 34 weeks → admit, ampicillin plus erythromycin or azithromycin, betamethasone, magnesium if <32 weeks; deliver at 34 weeks or sooner for infection
  • PPROM with fever, uterine tenderness, abruption or abnormal tracing → deliver regardless of gestational age
  • Painless bright-red bleeding in the third trimester → placenta previa until proven otherwise; ultrasound before any digital exam
  • Placenta previa → pelvic rest; cesarean at 36–37 weeks if stable, emergency cesarean for heavy bleeding or fetal compromise
  • Low-lying placenta at the anatomy scan → repeat ultrasound around 32 weeks; most move away from the cervix
  • Previa over a prior cesarean scar → placenta accreta spectrum; plan cesarean hysterectomy at 34–35 weeks at a specialty center
  • Painful bleeding, tense tender uterus after trauma, cocaine or hypertension → abruption; large IVs, CBC, fibrinogen, type and cross; deliver if unstable
  • Abruption with fetal death → expect DIC; replace fibrinogen and blood products, vaginal delivery usually preferred
  • Bleeding at membrane rupture with fetal bradycardia or sinusoidal pattern → vasa previa; emergency cesarean
  • Pregnant trauma patient past 20 weeks → left uterine displacement, at least 4 h fetal monitoring, Kleihauer-Betke if Rh-negative to dose anti-D
  • Maternal cardiac arrest with uterus at or above the umbilicus → manual uterine displacement during CPR; perimortem cesarean if no pulse by 4 minutes
  • Estimated fetal weight below the 10th percentile → umbilical artery Doppler; absent or reversed end-diastolic flow moves delivery earlier
  • Deepest fluid pocket <2 cm → oligohydramnios; check for ruptured membranes, growth restriction or renal anomalies; isolated at 36–37 weeks → deliver
  • Deepest fluid pocket ≥8 cm → polyhydramnios; test for diabetes and look for fetal swallowing problems such as GI obstruction or neural tube defects
  • Monochorionic twins → ultrasound every 2 weeks from 16 weeks to catch twin-twin transfusion
  • Stillbirth evaluation → Kleihauer-Betke, antiphospholipid antibodies, fetal autopsy, placental pathology and genetic testing by microarray

Traps that cost points

  • Doing a digital cervical exam for painless third-trimester bleeding→ Fingers can tear a previa and trigger hemorrhage; locate the placenta by ultrasound first.
  • Starting tocolysis at 35 weeks to buy time→ Past 34 weeks tocolysis does not improve outcomes; allow delivery.
  • Continuing tocolysis beyond 48 hours→ Its only purpose is finishing steroids or transfer; maintenance tocolysis adds harm without benefit.
  • Checking the cervix digitally in suspected PPROM→ It raises infection risk and shortens latency; use a sterile speculum exam.
  • Discharging a pregnant patient soon after a minor car crash→ Abruption can declare itself hours later; monitor the fetus at least 4 hours at viable gestation.
  • Using Kleihauer-Betke to diagnose abruption→ It measures fetal blood in maternal circulation to dose anti-D; abruption is a clinical and ultrasound-supported diagnosis.
  • Giving magnesium for neuroprotection at 34 weeks→ The neuroprotective benefit is shown only before 32 weeks.

Vaginitis, STIs & acute pelvic pain

In the Brain

Diagnose vaginitis at the microscope, treat STIs and partners with current regimens, and never miss torsion or ectopic in pelvic pain.

Rules to know

  • Thin gray discharge, fishy odor, pH >4.5, clue cells → bacterial vaginosis; oral metronidazole for 7 days or vaginal gel; male partners not treated
  • Thick white discharge, itching, normal pH, hyphae on KOH → vulvovaginal candidiasis; single-dose oral fluconazole, topical azole in pregnancy
  • Four or more yeast infections a year → confirm by culture, then weekly fluconazole for 6 months after an initial course
  • Frothy discharge, strawberry cervix, positive trichomonas NAAT → metronidazole 500 mg twice daily for 7 days; treat partners, retest in 3 months
  • Cervicitis or positive chlamydia NAAT → doxycycline 100 mg twice daily for 7 days; azithromycin 1 g if pregnant, with test of cure
  • Gonorrhea → ceftriaxone 500 mg IM once (1 g if ≥150 kg); add doxycycline unless chlamydia has been excluded
  • After chlamydia, gonorrhea or trichomonas → retest in 3 months for reinfection; offer expedited partner therapy where allowed
  • Chlamydia and gonorrhea screening → yearly for sexually active women under 25 and older women at increased risk
  • Painless genital ulcer with firm edges → primary syphilis; benzathine penicillin G 2.4 million units IM once, nontreponemal titers at 6 and 12 months
  • Syphilis of unknown duration or late latent → benzathine penicillin weekly for 3 weeks; neurologic, eye or ear symptoms → IV penicillin for neurosyphilis
  • Fever, myalgia and headache hours after syphilis treatment → Jarisch-Herxheimer reaction; antipyretics and continue therapy
  • Painful grouped vesicles or shallow ulcers → genital HSV; lesion PCR, antivirals 7–10 days for a first episode; frequent recurrences → daily suppression
  • Painful ulcer with tender suppurative nodes → chancroid (azithromycin or ceftriaxone); small painless ulcer then large tender nodes → LGV (doxycycline 21 days)
  • Genital warts → patient-applied imiquimod or podofilox, or office cryotherapy; in pregnancy use cryotherapy or excision
  • Sexually active patient with cervical motion, uterine or adnexal tenderness → treat empirically for PID; do not wait for NAAT results
  • Outpatient PID → ceftriaxone 500 mg IM once plus doxycycline and metronidazole for 14 days; reassess in 72 h
  • PID needing admission → pregnancy, tubo-ovarian abscess, high fever, vomiting, failed oral therapy or possible surgical emergency; IV antibiotics
  • Tubo-ovarian abscess → IV antibiotics; drainage if large, no response in 48–72 h, or rupture
  • PID with right upper quadrant pain and normal liver tests → perihepatitis (Fitz-Hugh-Curtis); same PID treatment
  • Pelvic pain in a reproductive-age woman → pregnancy test first, then pelvic ultrasound
  • Sudden one-sided pelvic pain, nausea, adnexal mass → ovarian torsion; Doppler ultrasound, but normal flow does not exclude it; laparoscopic detorsion saving the ovary
  • Brief one-sided pain at midcycle, normal exam → mittelschmerz; reassurance
  • Ruptured hemorrhagic cyst with mild free fluid, stable → pain control and observation; unstable → surgery
  • Simple ovarian cyst up to 10 cm without symptoms → expectant care, even after menopause; repeat ultrasound for larger ones
  • Painful swelling at the lower vaginal opening → Bartholin abscess; drain with a Word catheter or marsupialization, biopsy if 40 or older
  • Itchy, thin white vulvar skin in a figure-of-8 pattern → lichen sclerosus; high-potency topical steroid, biopsy persistent or atypical areas, lifelong cancer follow-up
  • Sexual assault survivor → consent-based exam and evidence collection, emergency contraception, empiric ceftriaxone, doxycycline and metronidazole, HIV PEP within 72 h, hepatitis B vaccine
  • Doxycycline post-exposure prophylaxis → gay or bisexual men and transgender women with a bacterial STI in the past year: doxycycline 200 mg within 72 h after condomless sex

Traps that cost points

  • Treating the male partner of a woman with bacterial vaginosis→ Partner therapy does not prevent recurrence; trichomonas is the vaginitis that needs partner treatment.
  • Using azithromycin first for chlamydia in a nonpregnant patient→ Seven days of doxycycline cures more, especially rectal infection; azithromycin is for pregnancy or adherence concerns.
  • Waiting for NAAT results before treating suspected PID→ Delay raises infertility and ectopic risk; minimal exam criteria justify immediate empiric therapy.
  • Ruling out torsion because Doppler shows flow→ Flow can be intermittent or preserved; strong clinical suspicion means laparoscopy.
  • Removing a dark ovary at torsion surgery→ Most dusky ovaries recover after detorsion; untwist and preserve it.
  • Treating syphilis in a penicillin-allergic pregnant patient with doxycycline→ Only penicillin reliably prevents congenital syphilis, and doxycycline harms fetal teeth and bone; desensitize and give penicillin.
  • Giving a single 2 g metronidazole dose for trichomonas in a woman→ The 7-day course cures more often in women; the single dose is kept for men.
  • Skipping HIV PEP after assault because 60 hours have passed→ PEP is offered up to 72 hours; start it at once.

Contraception, abortion care & infertility

In the Brain

Match the method to the medical history, give emergency contraception fast, and work up infertility in a set order.

Rules to know

  • Most effective reversible contraception → implant and IUDs; appropriate first-line choices for adolescents and nulliparous patients
  • Starting contraception → same-day start once pregnancy is reasonably excluded; backup for 7 days unless started within 5 days of period onset; no pelvic exam needed
  • Migraine with aura, smoker over 35, prior VTE or thrombophilia → no estrogen (same for lupus with antiphospholipid antibodies); progestin-only method or copper IUD
  • BP ≥160/100, ischemic heart disease, stroke or diabetes with vascular disease → avoid combined hormonal methods
  • Current breast cancer → no hormonal method of any kind; copper IUD
  • On rifampin, carbamazepine, phenytoin or other enzyme inducers → pills, patch, ring and implant may fail; choose an IUD or DMPA
  • Lamotrigine plus a combined estrogen pill → estrogen lowers lamotrigine levels; monitor levels or choose a non-estrogen method
  • After malabsorptive bariatric surgery → avoid oral contraceptives; use a non-oral method
  • DMPA every 13 weeks → reversible bone density loss (no DXA needed), weight gain, fertility may take 10 or more months to return
  • Heavy menstrual bleeding and wants contraception → levonorgestrel IUD; the copper IUD tends to worsen bleeding and cramps
  • Unprotected sex within 5 days → IUD (copper or 52-mg levonorgestrel) most effective; ulipristal to 120 h; oral levonorgestrel to 72 h, weaker with BMI >30
  • After ulipristal emergency contraception → wait 5 days before starting hormonal contraception, using condoms meanwhile
  • Pregnancy with an IUD in place → exclude ectopic; intrauterine pregnancy with visible strings → remove the IUD
  • IUD strings not seen → pregnancy test, backup method, ultrasound; not in the uterus → abdominal x-ray and laparoscopic removal if perforated
  • PID with an IUD in place → treat with antibiotics and leave the IUD unless there is no improvement in 48–72 h
  • Wants permanent contraception → vasectomy is safer and more effective; tubal sterilization by full salpingectomy also lowers ovarian cancer risk
  • Unintended pregnancy → nondirective options counseling (continuing and parenting, adoption, abortion) and timely referral for the care chosen
  • Medication abortion through about 10–11 weeks → mifepristone, then misoprostol 24–48 h later; confirm completion by hCG, ultrasound or symptom check
  • Before medication abortion → exclude ectopic when there are risk factors or uncertain dates; remove any IUD first
  • When to start infertility evaluation → after 12 months of trying if under 35, 6 months at 35–39, at once if 40 or older or with known problems
  • Infertility workup → semen analysis, ovulation check (cycle history, midluteal progesterone), tubal patency by hysterosalpingogram, ovarian reserve (AMH, antral follicle count)
  • Anovulatory infertility from PCOS → letrozole first-line for ovulation induction, plus weight loss if obese
  • Blocked tubes, severe male factor or failed simpler treatment → IVF, with ICSI for severe male factor
  • Abdominal swelling, ascites and hemoconcentration after ovulation induction → ovarian hyperstimulation syndrome; severe → admit, fluids, VTE prophylaxis, paracentesis if tense
  • Cancer diagnosis in a reproductive-age patient → fertility preservation referral before chemotherapy or pelvic radiation
  • Scant or absent periods and infertility after a D&C → Asherman syndrome; hysteroscopy to confirm and lyse adhesions
  • Turner syndrome planning pregnancy with donor eggs → cardiology review and aortic imaging first, because of dissection risk

Traps that cost points

  • Requiring a pelvic exam or Pap test before prescribing the pill→ Blood pressure and history are enough; exams are a barrier, not a requirement.
  • Prescribing a combined pill to a smoker over 35 or a patient with migraine with aura→ Estrogen raises stroke and clot risk here; offer a progestin-only method or an IUD.
  • Choosing oral levonorgestrel for a patient with BMI 35 seen 4 days after sex→ It is weaker with obesity and after 72 h; an IUD or ulipristal works better.
  • Pulling the IUD as soon as PID is diagnosed→ Treat with the device in place; remove it only if there is no clinical response.
  • Ordering DXA scans for patients on DMPA→ The bone loss reverses after stopping and does not justify scans or limit use.
  • Starting a long female workup before checking the partner's semen→ Male factor contributes in about half of couples; semen analysis is cheap and comes early.
  • Using clomiphene first for PCOS-related infertility→ Letrozole yields more ovulation and live births in PCOS.
  • Asking a 38-year-old to try for a full year before evaluation→ From 35, evaluate after 6 months; from 40, evaluate right away.

Menstrual disorders, PCOS & endometriosis

In the Brain

Pregnancy test first, then sort bleeding by age and structure, and amenorrhea by uterus, breasts and FSH.

Rules to know

  • Abnormal uterine bleeding in reproductive years → pregnancy test first, then CBC, TSH and pelvic ultrasound guided by structural vs nonstructural causes
  • Abnormal bleeding at 45+, or younger with unopposed estrogen → endometrial biopsy (also after failed medical therapy); obesity and PCOS count as unopposed estrogen
  • Heavy bleeding since menarche, or bleeding with dental work or surgery → screen for von Willebrand disease
  • Acute heavy uterine bleeding, unstable → resuscitate; IV conjugated estrogen or high-dose combined pill, tranexamic acid; D&C if medical therapy fails
  • Chronic heavy menstrual bleeding without a structural cause → levonorgestrel IUD, combined pills, tranexamic acid or NSAIDs during menses
  • Heavy bleeding with an enlarged irregular uterus → fibroids; ultrasound; LNG IUD, GnRH antagonist with add-back, myomectomy if fertility wanted, embolization, hysterectomy
  • Submucosal fibroid with heavy bleeding or infertility → hysteroscopic resection
  • Uniformly enlarged, soft, tender uterus with heavy painful periods → adenomyosis; ultrasound or MRI, hormonal therapy, hysterectomy is definitive
  • Primary amenorrhea → no menses by 15, or 3 years after breast budding; start with pregnancy test and exam for breasts and uterus
  • Breasts present, uterus absent → müllerian agenesis (female testosterone) vs androgen insensitivity (male-range testosterone, gonadectomy usually after puberty)
  • No breast development with high FSH → gonadal failure; karyotype for Turner syndrome; low FSH → hypothalamic or pituitary cause
  • Secondary amenorrhea → pregnancy test, then TSH, prolactin and FSH; add androgen levels if hirsute
  • Amenorrhea in an athlete or with low weight → functional hypothalamic amenorrhea; low FSH and estrogen; restore energy balance and check bone density
  • Amenorrhea before 40 with menopausal-range FSH on repeat → primary ovarian insufficiency; karyotype, FMR1 premutation, adrenal antibodies; hormone therapy until about 51
  • Irregular cycles with hirsutism or acne → likely PCOS; exclude pregnancy, thyroid disease, high prolactin and nonclassic CAH (17-hydroxyprogesterone)
  • PCOS diagnosis → two of three: oligo-ovulation, clinical or lab hyperandrogenism, polycystic ovaries or high AMH in adults
  • PCOS not seeking pregnancy → combined hormonal contraception for cycles, hirsutism and endometrial protection; add spironolactone after 6 months if needed
  • PCOS long-term care → screen for diabetes (OGTT or A1c), lipids, sleep apnea and depression; modest weight loss improves ovulation
  • Rapid virilization or testosterone >200 ng/dL → androgen-secreting tumor; pelvic ultrasound, DHEAS and adrenal CT
  • Painful periods beginning with ovulatory cycles, normal exam → primary dysmenorrhea; NSAIDs, then hormonal contraception
  • Cyclic pelvic pain, dyspareunia, painful defecation, infertility, uterosacral nodules → endometriosis; NSAIDs plus continuous hormonal suppression empirically
  • Endometriosis failing hormonal therapy or with infertility → laparoscopy to confirm and excise; GnRH antagonist or agonist with add-back is second-line
  • Luteal-phase mood symptoms that impair function and lift with menses → PMDD; SSRI daily or luteal-only, or a drospirenone pill
  • Postcoital bleeding → cervical screening if due, chlamydia and gonorrhea testing, and speculum look for polyp or lesion

Traps that cost points

  • Ordering hormone levels before a pregnancy test in amenorrhea→ Pregnancy is the most common cause at every age; test first.
  • Skipping endometrial sampling in an obese 38-year-old with irregular heavy bleeding→ Unopposed estrogen raises risk regardless of age; biopsy the endometrium.
  • Requiring laparoscopy before treating suspected endometriosis→ Empiric NSAIDs and hormonal suppression come first; surgery is for failure or infertility.
  • Using metformin as the main treatment for PCOS cycles and hirsutism→ Combined hormonal contraception is first-line; metformin helps metabolic risk.
  • Starting spironolactone for hirsutism without contraception→ It can feminize a male fetus; pair it with reliable contraception.
  • Telling a patient with primary ovarian insufficiency she cannot conceive→ Intermittent ovulation persists in some; counsel contraception if pregnancy is unwanted.
  • Treating an amenorrheic athlete with calcium and vitamin D alone→ Low estrogen from low energy availability drives bone loss; restoring intake and weight is the treatment.

Postpartum care & complications

In the Brain

Bleeding first, then fever, mood and feeding: know the uterotonic order and which postpartum symptoms are emergencies.

Rules to know

  • Postpartum hemorrhage (≥1,000 mL or bleeding with hypovolemia) → call for help, two large IVs, bimanual massage, IV oxytocin, find the cause: tone, trauma, tissue, thrombin
  • Boggy uterus despite oxytocin → add methylergonovine (not with hypertension), carboprost (not with asthma) or misoprostol
  • Postpartum hemorrhage within 3 hours of birth → tranexamic acid 1 g IV alongside uterotonics
  • Firm uterus but ongoing bleeding → inspect for cervical, vaginal or perineal lacerations and hematoma; repair
  • Placenta not out by 30 minutes or missing pieces → manual removal under anesthesia; no cleavage plane suggests accreta, prepare for hysterectomy
  • Bleeding persisting after uterotonics → balloon or vacuum tamponade, then embolization or surgery (compression sutures, artery ligation, hysterectomy); activate massive transfusion
  • Shock out of proportion to bleeding, fundus not palpable → uterine inversion; stop uterotonics, replace the uterus manually, then oxytocin
  • Sudden hypoxia, hypotension and DIC during or just after delivery → amniotic fluid embolism; CPR, ventilation, pressors and blood products
  • No milk and no periods after massive postpartum hemorrhage → Sheehan syndrome; check cortisol first, then thyroid and other pituitary hormones
  • Fever after cesarean with uterine tenderness and foul lochia → endometritis; IV clindamycin plus gentamicin until afebrile 24–48 h, no oral step-down needed
  • Postpartum fever persisting despite antibiotics → CT for pelvic abscess or septic pelvic thrombophlebitis; thrombophlebitis needs anticoagulation
  • Nursing mother with tender red wedge of breast and fever → mastitis; keep emptying that breast, dicloxacillin or cephalexin; MRSA risk → clindamycin
  • Fluctuant tender breast mass while nursing → breast abscess; ultrasound-guided aspiration or drainage plus antibiotics; breastfeeding can continue
  • Tearful mood swings that resolve within 2 weeks of birth → postpartum blues, peaking around days 3–5; reassure and recheck
  • Depressive symptoms beyond 2 weeks in the year after birth → postpartum depression; screen with a validated tool at postpartum and infant visits
  • Postpartum depression → psychotherapy and/or an SSRI (sertraline is well studied in breastfeeding); zuranolone is an oral 14-day option
  • Confusion, hallucinations or bizarre thoughts in the first postpartum weeks → postpartum psychosis; emergency psychiatric admission and an infant safety plan
  • Palpitations months after birth, painless thyroid, low uptake → postpartum thyroiditis; beta-blocker only, then watch for a hypothyroid phase
  • Heart failure late in pregnancy or up to 5 months postpartum → peripartum cardiomyopathy if EF <45%; standard heart failure therapy, ACE inhibitors only after delivery
  • Headache or BP ≥160/110 within 6 weeks after birth → postpartum preeclampsia; magnesium and antihypertensives, even after a normotensive pregnancy
  • Hypertensive disorder of pregnancy → BP check within 72 h of discharge if severe, otherwise within 7–10 days
  • Postpartum follow-up → contact within 3 weeks and a comprehensive visit by 12 weeks
  • Nonimmune to rubella or varicella → vaccinate before discharge; safe with breastfeeding, avoid pregnancy for 1 month
  • Rh-negative mother of an Rh-positive newborn → rosette screen, Kleihauer-Betke if positive to size the dose, anti-D within 72 hours
  • Postpartum contraception → implant, IUD and progestin-only methods can start right away; combined estrogen waits at least 21 days, longer with clot risk or breastfeeding
  • Exclusive breastfeeding, no periods, infant under 6 months → lactational amenorrhea is about 98% effective; add contraception when any condition lapses
  • Pain relief while breastfeeding → ibuprofen and acetaminophen first; avoid codeine and tramadol (ultrarapid metabolism can harm the infant)
  • Medications while breastfeeding → most antibiotics, SSRIs, heparin, warfarin and antiseizure drugs are compatible; avoid DOACs, radioactive iodine and chemotherapy

Traps that cost points

  • Giving methylergonovine for hemorrhage in a patient with preeclampsia→ Ergots cause intense vasoconstriction and hypertensive crisis; use carboprost or misoprostol.
  • Giving carboprost to a patient with asthma→ Prostaglandin F2-alpha triggers bronchospasm; choose methylergonovine if normotensive, or misoprostol.
  • More massage and uterotonics when the uterus is already firm→ A firm uterus points to lacerations, retained tissue or coagulopathy; inspect and check clotting.
  • Telling a mother with mastitis to stop breastfeeding→ Continued emptying speeds recovery and the milk is safe for the infant.
  • Calling postpartum psychosis the baby blues→ Hallucinations or confusion threaten mother and infant; this needs emergency admission.
  • Starting methimazole for postpartum thyroiditis→ The thyroid is leaking stored hormone, not making more; treat symptoms with a beta-blocker.
  • Dismissing severe headache a week after a normotensive delivery→ Preeclampsia can first appear up to 6 weeks postpartum; check BP and labs, give magnesium if severe.
  • Prescribing codeine for post-cesarean pain to a nursing mother→ Ultrarapid metabolizers pass morphine to the infant; use NSAIDs and acetaminophen first.

Menopause & gender-affirming hormone care

In the Brain

Treat symptoms with the right hormone in the right patient, and monitor gender-affirming hormones on a steady lab schedule.

Rules to know

  • Over 45 with 12 months without periods and hot flashes → menopause is a clinical diagnosis; FSH testing is unnecessary
  • Bothersome hot flashes, under 60 or within 10 years of menopause → systemic hormone therapy is the most effective option if no contraindication
  • Hormone therapy with an intact uterus → add a progestogen to protect the endometrium; no uterus → estrogen alone
  • Hormone therapy candidate with clot or triglyceride concerns → transdermal estradiol rather than oral
  • Contraindications to systemic hormone therapy → breast or endometrial cancer, prior VTE or stroke, coronary disease, active liver disease, unexplained bleeding
  • Hot flashes when hormones are not an option → SSRI or SNRI (low-dose paroxetine, venlafaxine), gabapentin, or fezolinetant with liver test monitoring
  • Vaginal dryness, painful sex and urinary symptoms after menopause → genitourinary syndrome; moisturizers, lubricants, low-dose vaginal estrogen without a progestogen
  • Hormone therapy solely to prevent heart disease, dementia or fractures → not recommended; use it for symptoms
  • Years of combined estrogen-progestin → small rise in breast cancer risk; estrogen alone after hysterectomy has not shown this rise
  • Menopause before 40, natural or surgical → hormone therapy until about the usual age of menopause to protect bone and heart
  • Postmenopausal osteoporosis needing drug therapy → bisphosphonate first; hormone therapy protects bone but is chosen for symptoms
  • Irregular bleeding in perimenopause → still evaluate, and keep contraception until 12 months without periods after 50 or age 55
  • Before gender-affirming hormones → informed consent, baseline labs, and a fertility preservation discussion (sperm or egg banking)
  • Feminizing hormone therapy → estradiol (transdermal, oral or injectable) plus an androgen blocker such as spironolactone or a GnRH agonist; not ethinyl estradiol
  • On feminizing therapy → estradiol and testosterone every 3 months the first year, then 1–2 times yearly; aim estradiol 100–200 pg/mL, testosterone <50 ng/dL
  • Spironolactone as an androgen blocker → potassium and creatinine at baseline and after dose changes
  • Estrogen therapy with smoking, older age or prior VTE → highest clot risk; prefer transdermal estradiol and support quitting
  • Masculinizing hormone therapy → testosterone injection or gel; testosterone level and hematocrit every 3 months the first year, then 1–2 times yearly
  • Hematocrit above 54% on testosterone → lower the dose or lengthen the interval, look for sleep apnea and smoking
  • On testosterone with a uterus and ovaries → pregnancy is still possible and testosterone harms a fetus; counsel reliable contraception
  • Screening transgender patients → screen the organs present: cervix by usual schedule, breasts by tissue and hormone history, prostate by usual PSA discussion
  • After gonadectomy, or sex hormones stopped long-term → assess bone density, since sex steroids maintain bone

Traps that cost points

  • Ordering FSH to diagnose menopause in a 52-year-old with typical symptoms→ The diagnosis is clinical; FSH swings during the transition and adds nothing.
  • Prescribing estrogen alone to a woman with a uterus→ Unopposed estrogen causes endometrial hyperplasia and cancer; add a progestogen.
  • Refusing hormone therapy to a healthy 50-year-old with severe hot flashes→ Under 60 or within 10 years of menopause, benefits usually outweigh risks without contraindications.
  • Starting hormone therapy at 68 to prevent heart disease→ Late starts carry more cardiovascular and stroke risk, and hormones are not for disease prevention.
  • Avoiding vaginal estrogen for genitourinary syndrome because of systemic warnings→ Low-dose vaginal estrogen has minimal absorption and needs no progestogen.
  • Assuming testosterone prevents pregnancy→ Ovulation can still happen; counsel contraception because fetal exposure to testosterone is harmful.
  • Prescribing ethinyl estradiol for feminizing therapy→ It carries the highest clot risk; estradiol formulations are used instead.
  • Skipping cervical screening in a transgender man on testosterone→ A cervix still needs routine screening; HPV testing helps when atrophy makes cytology unsatisfactory.

USMLE®, NBME®, MCAT®, SAT®, ACT® and other names mentioned are trademarks of their owners, who are not affiliated with and do not endorse Ivy Tutoring, LLC or IvyMed.